Phelan-McDermid Syndrome (PMS) is a rare genetic condition caused by a deletion or mutation in the SHANK3 gene on chromosome 22q13. This genetic change leads to a range of developmental and neurological differences, often including significant developmental delays, intellectual disability, and challenges with communication and social interaction. While it is a distinct genetic syndrome, individuals with Phelan-McDermid Syndrome may exhibit characteristics that overlap with other neurodevelopmental conditions, such as autism spectrum disorder, and it is important to understand its unique genetic basis and impact. Early Indicators: Recognizing Physical Characteristics in Newborns with Down Syndrome Autism vs. Down Syndrome: Understanding Different Support Needs, Not ‘Worse’ or ‘Better’ Navigating Relationships: A Guide to Dating and Social Connections for Individuals with Down Syndrome This topic is closely connected to down syndrome vs autism.
What is Phelan-McDermid Syndrome?
Phelan-McDermid Syndrome is a neurodevelopmental disorder resulting from a missing segment of genetic material at the end of chromosome 22, specifically region 22q13.3, or a mutation within the SHANK3 gene located in that region. The SHANK3 gene plays a critical role in brain development and function, particularly in the formation and maintenance of synapses, which are the connections between nerve cells. When this gene is affected, it can disrupt normal brain signaling, leading to the diverse symptoms observed in individuals with PMS.
The condition is typically not inherited but occurs spontaneously (de novo) during the formation of reproductive cells or early embryonic development. However, in rare cases, it can be inherited from a parent who carries a balanced chromosomal rearrangement.
Key Characteristics and Developmental Impact
The developmental impact of Phelan-McDermid Syndrome varies widely among individuals, even within the same family. However, some common characteristics include:
- Developmental Delay and Intellectual Disability: Nearly all individuals with PMS experience global developmental delays, affecting motor skills, speech, and cognitive abilities. Intellectual disability can range from moderate to severe.
- Speech and Communication Challenges: Many individuals with PMS are nonverbal or have severely limited verbal communication. They may use alternative communication methods, such as sign language or augmentative and alternative communication (AAC) devices.
- Autistic-like Behaviors: A significant percentage of individuals with PMS are diagnosed with or exhibit traits consistent with autism spectrum disorder, including difficulties with social interaction, repetitive behaviors, and sensory sensitivities.
- Motor Skill Difficulties: Low muscle tone (hypotonia) is common, which can affect gross and fine motor development, leading to delays in sitting, walking, and coordination.
- Medical and Physical Features: While there are no universal physical features, some common findings include distinct facial features (e.g., long head, full eyebrows, prominent ears), large and fleshy hands, and issues such as gastrointestinal problems, seizures, and sleep disturbances.
- Behavioral Differences: Individuals may experience anxiety, mood swings, self-injurious behaviors, or hyperactivity.
Diagnosis of Phelan-McDermid Syndrome
Diagnosis of Phelan-McDermid Syndrome typically involves genetic testing. If a healthcare provider suspects a genetic cause for developmental delays or other symptoms, they may recommend:
- Chromosomal Microarray Analysis (CMA): This test can detect small deletions or duplications in chromosomes, including the 22q13 deletion.
- FISH (Fluorescence In Situ Hybridization): This test can specifically look for the 22q13 deletion.
- Gene Sequencing: If CMA or FISH are negative but PMS is still suspected, sequencing of the SHANK3 gene can identify point mutations or smaller deletions not detected by other methods.
Early diagnosis is crucial for accessing appropriate interventions and support services.
Support and Management
There is no cure for Phelan-McDermid Syndrome, but a comprehensive, individualized approach to management can significantly improve quality of life. Support strategies often include:
- Early Intervention Therapies: Physical therapy, occupational therapy, and speech-language therapy are essential to address developmental delays and improve functional skills.
- Behavioral Interventions: Applied Behavior Analysis (ABA) or other behavioral therapies can help manage challenging behaviors and teach adaptive skills, especially for those with co-occurring autism.
- Educational Support: Individualized Education Programs (IEPs) are vital to ensure children receive tailored educational services.
- Medical Management: Regular monitoring by specialists (neurologists, gastroenterologists, etc.) is important to address associated medical conditions like seizures, sleep issues, or gastrointestinal problems.
- Family Support: Connecting with support groups and organizations dedicated to Phelan-McDermid Syndrome can provide valuable resources and community.
Phelan-McDermid Syndrome, Down Syndrome, and Autism: A Comparison
While Phelan-McDermid Syndrome, Down Syndrome, and Autism Spectrum Disorder all impact development, they are distinct conditions with different genetic origins and characteristic profiles. Understanding these differences, as well as potential overlaps, is key to accurate diagnosis and targeted support. For more on the distinctions between autism and Down Syndrome, you can read our article on What is the Difference Between Autism and Down Syndrome?
| Condition | Primary Genetic Cause | Key Characteristics (Common) | Overlap with Autism Traits |
|---|---|---|---|
| Phelan-McDermid Syndrome (PMS) | Deletion or mutation of SHANK3 gene on chromosome 22q13 | Significant developmental delay, intellectual disability, severe speech impairment/nonverbal, hypotonia, some distinctive physical features, gastrointestinal issues, seizures. | High prevalence of autistic-like behaviors, social communication challenges, repetitive behaviors, sensory sensitivities. Often diagnosed with co-occurring ASD. |
| Down Syndrome | Trisomy 21 (extra copy of chromosome 21) | Intellectual disability (mild to moderate), distinctive facial features, hypotonia, heart defects, gastrointestinal issues, increased risk of certain health conditions. | Approximately 10-18% of individuals with Down Syndrome also have an autism diagnosis. Shared traits can include social communication challenges, repetitive behaviors, and sensory differences. For more, see Autism and Down Syndrome: Exploring the Intersections and Unique Support Needs. |
| Autism Spectrum Disorder (ASD) | Complex interaction of genetic and environmental factors (no single gene cause) | Persistent deficits in social communication and interaction, restricted, repetitive patterns of behavior, interests, or activities, sensory sensitivities. | Defined by these core traits. While PMS and Down Syndrome can co-occur with ASD, ASD itself is a neurodevelopmental condition primarily defined by these behavioral and developmental criteria. For more on distinguishing these conditions, refer to Untangling Diagnoses: Why Down Syndrome is Not Autism, and How They Can Co-Occur. |
Understanding Phelan-McDermid Syndrome as a distinct genetic condition, while acknowledging its potential overlaps with autism, helps ensure that individuals receive the most accurate diagnosis and appropriate, tailored support for their unique needs.
People Also Ask
What is the life expectancy for Phelan-McDermid Syndrome?
While Phelan-McDermid Syndrome is a lifelong condition, there is currently no specific data indicating a reduced life expectancy directly attributable to the syndrome itself. Life expectancy largely depends on the presence and severity of associated medical complications, such as seizures, heart defects, or kidney problems. With appropriate medical care and support, individuals with PMS can live into adulthood.
Is Phelan-McDermid Syndrome considered a form of autism?
No, Phelan-McDermid Syndrome is not considered a form of autism. It is a distinct genetic condition with a known genetic cause (deletion or mutation of the SHANK3 gene). However, a significant number of individuals with Phelan-McDermid Syndrome also meet the diagnostic criteria for autism spectrum disorder, meaning autism can be a co-occurring condition. The genetic changes in PMS are known to impact brain development in ways that can lead to autistic traits.
How rare is Phelan-McDermid Syndrome?
Phelan-McDermid Syndrome is considered a rare disease. Its exact prevalence is still being determined, but current estimates suggest it affects approximately 1 in 15,000 to 1 in 50,000 live births. It is likely underdiagnosed due to its rarity and the variability of its symptoms.
What are the main challenges for individuals with Phelan-McDermid Syndrome?
The main challenges for individuals with Phelan-McDermid Syndrome often include significant developmental delays, intellectual disability, severe speech and communication impairments (many are nonverbal), and difficulties with motor skills. Behavioral challenges, such as autistic-like behaviors, anxiety, and sleep disturbances, are also common. Medical issues like seizures and gastrointestinal problems can also present significant challenges.
Further reading: Autism Speaks
Further reading: Autistic Self Advocacy Network (ASAN)
Written by Marcus
Pharmacist and father of an autistic son
Transparency Note: This content is regularly reviewed and updated with the assistance of artificial intelligence to ensure technical accuracy and informational rigor, backed by personal lived experience and specialized curation.